Keros Therapeutics, Inc. · NASDAQ:KROS
Bienaime Jean Jacques bought 1,000 Keros Therapeutics, Inc. shares (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Bienaime Jean Jacques (Director) bought 1,000 Keros Therapeutics, Inc. shares at US$10.58 for US$10,580 under a trading plan, leaving 9,450 shares. Filed May 19, 2026 (Form 4).
- Bought
- 1,000 shares
- Price
- US$10.58
- Value
- US$10,580
- Holding after
- 9,450 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Buy | 1,000 | US$10.58 | 9,450 | Direct |
Source
Related
- Keros Therapeutics, Inc.
- Bienaime Jean Jacques
- Keros Therapeutics, Inc. shareholders
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026
- Form 4 · Bienaime Jean Jacques · Jul 17, 2026
- Form 4 · Bienaime Jean Jacques · Jun 17, 2026
- Form 4 · Bienaime Jean Jacques · Jun 5, 2026
- Form 4 · Bienaime Jean Jacques · Apr 17, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026